asthma 3.1.17 no notes (002) [read-only] -...
TRANSCRIPT
2/22/2017
1
Marianne Curran, PA‐C
3/1/17
Learning Objective
Discuss the pathophysiology, clinical presentation, diagnosis, and
treatment of Asthma
Asthma Definition – many variations
Chronic Disorder with Reversible (Intermittent & Recurring) Airflow Obstruction, Bronchial
Hyperresponsiveness with underlying inflammation
…+/‐ with Shortness of Breath, cough, wheezing
2/22/2017
2
Asthma – Why is this Important? Statistics
~17‐20 million U.S. Adults have asthma
~6‐7 million U.S. Children, most common chronic disease in children
2.o million ER visits with asthma S/S
~3,500 deaths in 2010 from asthma
Anatomy Review
Review of Lung Anatomy
2/22/2017
3
AsthmaThink of 3 things:
Airway Hyper‐Responsiveness
Inflammation
Airflow Obstruction
Review of Lung Anatomy
Asthma
2/22/2017
4
Asthma Demographics
Can be anyone
Urban > Rural population
Higher in minority populations
Asthma rates in black children increased 50% from ‘01 to ‘09
~1/2 develop > age of 10
~1/2 will have remission in adulthood
If develop as an adult, rarely goes into remission
Asthma Cause = Unknown
Genetic factor(s) present
Allergy plays a central role
AsthmaInflammation 1st
Lead to Hyperresponsiveness…
Bronchconstriction
Mucus hypersecretion
Airway edema
2/22/2017
5
Asthma Presentation
Wide range from mild to severe
Can be intermittent and non‐specific
Episodic shortness of breath with/without wheezing, cough (usually worse at night), sputum production
To Dx – need symptoms of the above + reversible expiratory airflow obstruction
Can look like many other conditions…
Asthma DDx:
Other pulmonary diseases; emphysema, chronic bronchitis, bronchiectasis
Chronic rhinosinusitis Vocal cord dysfunction (VCD) Cystic Fibrosis Heart Failure Pulmonary Embolism Foreign Body in the airway Obesity GERD Upper Respiratory Tract infection
AsthmaHistory
2/22/2017
6
AsthmaHistory Age at onset Exacerbation details; how frequent, duration, limitations Patterns; time of day, time of week, etc – look for triggers Family history Current medications Smoker? now or in the past? Past medication history (ACEI)
h/o Allergic manifestations
Number/freq. of ER visits Ever been hospitalized with asthma attack Ever been on a ventilator due to asthma attack
AsthmaTriggers – can be inhaled or systemic antigens
Smoke
Perfumes
Dust
Animals
Other pollutants
Cold air, dry air
Exercise
Illness
AsthmaHistory
ROS:
General
Skin
HEENT
Pulm
Cardiac
2/22/2017
7
AsthmaPhysical exam
No abnormal signs or many if in acute phase
Wheezing – especially during expiratory phase
Prolonged expiratory phase
Accessory respiratory muscles
Active expiration
Increase AP diameter = Barrel chest
Diaphoretic, tachycardia, elevated respiration rate
Asthma Samter’s syndome
1. Asthma
2. Nasal Polyps
3. Sensitivity to NSAIDs
....almost always a Board question
Important to educate these patients to avoid NSAIDs
Asthma Studies:
Spirometry (Spiro) is the gold standard
Easy – but is effort dependent
Fast
Inexpensive
Serial studies helpful
Baseline – get one
2/22/2017
8
Asthma Studies:
Spirometry cont.
FEV1: Forced Expiratory Volume in 1 second
Decreased in Asthma
Normal > 80%
FVC: Forced Expiratory Volume
Normal > 80%
FEV1/FVC Ratio: This is what you use to determine obstruction
Less than 70% = obstructive process
Asthma Spiro
Asthma Spiro
2/22/2017
9
Asthma Spiro
Asthma Spirometry cont.
DO A POST
Asthma Studies: cont.
Labs ‐‐ Serum IgE
CXR
Bronchial challenge aka Bronchoprovocation testing
Allergy testing
Peak Expiratory Flows (PEF) ‐‐>
Pulse oximetry
Arterial Blood Gas (ABG) – for acute settings
CPFT
2/22/2017
10
AsthmaClassification of asthma severity
Spirometry results
Frequency of symptoms
Nighttime symptoms
Frequency of Rescue Inhaler use
ADLs
AsthmaClassification of asthma severity
Mild intermittent
Mild persistent
Moderate persistent
Severe persistent
AsthmaClassification of asthma severity Mild intermittent:
Occasional symptoms ≤2/wk Asymptomatic & normal pulm. function (aka spirometry) between exacerbations
Exacerbations brief (few hrs to few days) Nocturnal symptoms ≤2/month Use of rescue inhaler ≤2/week
Mild persistent: Symptoms > 2/week, but <1/day Exacerbations may affect activities Nocturnal symptoms > 2/month Use of rescue inhaler > 2 days/week (not daily) FEV1 ≥ 80% predicted
2/22/2017
11
AsthmaClassification of asthma severity Moderate persistent:
Daily symptoms; interfere with activities Exacerbations ≥2/week; may last days Nocturnal symptoms > 1/week Daily use of rescue inhaler FEV1 ≥ 60% predicted, but < 80% predicted
Severe persistent: Continual symptoms ‐ daily Limited physical activities Nocturnal symptoms – usually nightly Frequent exacerbations Frequent nocturnal symptoms FEV1 < 60% predicted
AsthmaTreatment
Most important aspect...
Asthma
EDUCATION
2/22/2017
12
AsthmaPatient Education – To achieve optimal status:
ADLs
Rescue Inhaler use
Nocturnal symptoms
Normal/or as normal as you can get it – lung functions on serial spirometry
Maintenance medication: lowest doses/combination possible to achieve the above (ideally no side effects)
Reduce ER visits
Reduce oral corticosteriod use
AsthmaPatient Education
Avoid triggers If they have allergies to dust, mites, smoke, pets, environmental items
Treat allergies: Consider immunotherapy/allergy shots
Timing of Rescue inhaler
PEFs: Stepping up/down in their treatment plan
When to obtain treatment, seek ER
How to take their medications – especially inhalers
Other items to avoid: NSAIDs, ASA, non‐selective B‐blocker
NOOOOO smoking, avoid 2nd hand smoke
Yearly flu vaccine
AsthmaTreatment – Medications
Two main categories Quick relief
Rescue, taken as‐needed
Goal is to promptly reverse airflow obstruction & relieve symptoms
Examples: short‐acting B2‐agonists, anticholinergics
Long term Control, taken daily to maintain
Examples: long‐acting B2‐agonists, corticosteroids, leukotriene modifiers, theophylline
2/22/2017
13
AsthmaMedications – Delivery options
Majority are via Metered Dose Inhalers (MDIs)
Nebulization
AsthmaMedications B2‐agonists
Produce bronchodilation Side effects: Tremor & tachycardia Two types:
Short‐acting Quick relief for acute symptoms; aka Rescue Inhaler
Can also use prior to exercise if EIB Rapid onset w/in 5‐10 minutes; duration of 3‐6 hours Examples: albuterol, levalbuterol, pirbuterol
Long‐acting aka LABA Long term control Onset within 15‐30 minutes; duration of 12 hours Examples: Salmeterol (serevent), formoterol (foradil), Brovana
(arformoterol)
AsthmaTreatment
Corticosteroids
Decrease airway inflammation and hyperresponsiveness
Decrease frequency of exacerbations
Decrease severity of asthma symptoms
Up‐regulate expression & affinity of B2‐receptors in lung
Different routes of delivery
2/22/2017
14
AsthmaTreatment
Inhaled corticosteroids (ICS) Decrease airway inflammation
Very effective
Better to add a 2nd long‐acting med than initially increase dose of ICS
Side effects: cough, dysphonia, thrush
Examples: fluticasone (flovent), budesonide (pulmicort), beclamethasone (Qvar), Triamcnolone(Azmacort), others
NOT a rescue inhaler and NOT to be use as‐needed
AsthmaTreatment
Systemic corticosteroids
Can be delivered orally, IV, IM
Reduce rate of hospital visits, shorten duration of exacerbations and reduce risk of relapse
Typically used for exacerbations or for severe persistent
If long‐term use; TAPER
Side effects: Osteoporosis, hyperglycemia, cataracts, weight gain, mood swings, insomnia, suppress hypothalamic‐pituitary‐adrenal axis
AsthmaTreatment
Combined ICS and long acting beta‐agonists
Combines two medications into one inhaler
Examples: Symbicort (budesonide & formoterol), Advair (fluticasone & formoterol), Dulera (mometasone& formoterol)
NOT a rescue inhaler and NOT to be use as‐needed
2/22/2017
15
AsthmaMedications
Leukotriene modifiers:
Allows a decrease in the cellular infiltration of asthmatic bronchial mucosa
Side effects: Drowsiness, GI symptoms, headache
Example: Singulair (QD) and Zafirlukast/Accolate(BID)
AsthmaMedications Anticholinergic drugs
Produces bronchodilator Low side effect profile; dry mouth Typically slower onset than B2‐agonists Examples:
Atrovent (ipratropium bromide): MDI and solution/SVN, short‐acting Spiriva (tiotrpium bromide): handihaler, long‐acting
Theophylline Produces bronchodilation, increased mucociliary clearance, increased diaphragmatic muscle contraction
Side effects; insomnia, GERD, GI symptoms, nausea, tremor (and many drug interactions)
Need to measure blood levels – watch for toxicity
AsthmaTreatment – Misc.
Omalizumab/Xolair
Reduces sensitivity to allergens – used for moderate to severe allergic asthmatics
Route: subcutaneous every 2‐4 wks (depending on IgElevels & body weight)
Side effects: anaphylaxis – pts watched in office after each injection
2/22/2017
16
AsthmaBack to our classifications...
Mild intermittent
Mild persistent
Moderate persistent
Severe persistent
AsthmaTreatment
Mild intermittent: short‐acting B2‐agonists PRN
Mild persistent: 1st line: low‐dose inhaled corticosteroid (ICS)
2nd line: long‐acting B2‐agonist, leukotriene modifiers, theophylline
Moderate persistent: low‐dose ICS PLUS one of the other long‐term control med
Severe persistent: high‐dose ICS plus one of the other long‐term control meds. Usually need systemic corticosteroids
AsthmaTreatment: Step protocol
Step 1: Rescue inhaler as needed
Step 2: Low dose ICS
Step 3: Low dose ICS & long‐acting beta‐agonist OR medium dose ICS
Step 4: Medium dose ICS & long‐acting beta‐agonist
Step 5: High dose ICS & long‐acting beta‐agonist
Step 6: High dose ICS & long‐acting beta‐agonist + oral steroids
2/22/2017
17
AsthmaTreatment
Monitor these patients
More frequent with medication changes
More frequent with change in S/S
Serial spirometry studies in office
Peak Flow monitoring at home
Create a formal written action plan based on peak flow changes
AsthmaSpecial cases
Exercise induced asthma
Usu. controlled w/short‐acting B2‐agonist 15‐30 minutes prior to exercise
Nocturnal asthma
Aspirin sensitivity asthma
Consider leukotrienes modifiers
Pregnancy
Pre‐surgical evaluation
AsthmaNon‐responders
Consider Bronchial Challenge test
Consider concomitant conditions that are not optimally treated:
GERD
VCD
Sleep Apnea
Chronic rhinitis
Chronic sinusitis
2/22/2017
18
AsthmaAcute Exacerbation
Signs: Tachypnea
Tachycardia
Tri‐pod position
Difficulty speaking in complete sentences
Accessory muscle use
O2 – 90%
Hypercapnia
Get to it early! How severe?
Remove triggers if possible
Think ER, think IV steroids
AsthmaComplications:
Immediate: Status asthmaticus
Acute, life threatening, sustained & severe airway obstruction refractory to treatment.
Carbon dioxide retention, hypoxemia and respiratory failure
Need ER/hospital
Long‐term if not optimally treated: Airway Remodeling causes Fixed airway obstruction
AsthmaIn conclusion
Investigate – ask questions
Lots of treatment/Rx options – base on severity
Can step up and can step down
Remove triggers when possible
2/22/2017
19
Asthma
Questions
References1. Manual of Clinical Problems in Pulmonary Medicine 5th edition. By Richard
A. Bordow2. www.cdc.gov3. www.nhlbi.nih.gov/.../asthma/asthstat.pdf 4. www.medscape.com
EDB24
Slide 57
EDB24 You should have a slide of your references for each lecture.Emily D Babcock, 2/18/2014